Health
health and longevity · the day's top 10 · june 10th
storyflo · health and longevity
Jun 10, 2026 · 2 min listen
Listen · storyflo · health and longevity
health and longevity · the day's top 10 · june 10th
0:00-1:46
Live · Kokoro-82M
(MedPage Today) -- Investigational apitegromab -- a selective myostatin activation inhibitor -- effectively preserved lean mass when combined with tirzepatide (Zepbound) in a randomized phase II trial, suggesting it could help fight "Ozempic...
No matter how you sauce them, this is a perfect base method to baking wings. Sauce it however you want; doesn’t affect my life. 5 pounds chicken wings, tips removed 1 teaspoon baking powder 1 teaspoon cornstarch 1 teaspoon salt Preheat oven to 450°F, and place the oven rack on the middle level. I like to use convection, but not required. While oven is heating, toss wings with baking powder, cornstarch, and salt.
GSK’s Nuvalent acquisition brings two lead programs, each addressing different targets for non-small cell lung cancer. The Nuvalent lung cancer drugs are under FDA review and if they’re approved, GSK plans to launch both this year. The post GSK Gets a Pair of Near-Commercial Lung Cancer Drugs via $10.6B Nuvalent Acquisition appeared first on MedCity News.
(MedPage Today) -- A low lipoprotein(a) level was tied to incident diabetes in the FOURIER trial. (European Heart Journal) People with 1.5 to 2 hours of strength training a week typically lived longer in a pooled cohort study.
Merck & Co. and Gilead are pulling the plug on the phase 3 Evoke-03 trial evaluating Trodelvy, combined with Keytruda, as a first-line treatment in patients with PD-L1-high non-small cell lung cancer.
Inclusion on the Pentagon’s 1260H list automatically makes WuXi AppTec one of the “biotechnology companies of concern” under the Biosecure Act. WuXi AppTec maintains that its place on the list was "clearly a mistake," a spokesperson said.
Today, the U.S. Food and Drug Administration added bemotrizinol to the list of permitted sunscreen active ingredients, marking a significant milestone in the agency's efforts to advance sunscreen innovation.
(MedPage Today) -- The phase III OPTIMA trial, presented at this year's American Society of Clinical Oncology (ASCO) annual meeting, showed that some patients with high-risk, early-stage, estrogen receptor (ER)-positive, HER2-negative breast cancer...
(MedPage Today) -- NEW ORLEANS -- Treatment with investigational elecoglipron led to weight loss in people with obesity and improved glucose control in those with type 2 diabetes, a pair of global phase II randomized trials showed.
(MedPage Today) -- The first dedicated U.S. guideline for cardiovascular-kidney-metabolic (CKM) syndrome makes a big push to unite primary and specialty care in managing large swaths of the population. The American Heart Association (AHA) and...
Send this story to anyone — or drop the embed into a blog post, Substack, Notion page. Every play sends rev-share back to storyflo · health and longevity.
We’ve simplified responses to 👍 / 👎. Past comments are archived but no longer visible.